Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol (SONAR-12)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01526434
Recruitment Status : Completed
First Posted : February 3, 2012
Last Update Posted : March 19, 2014
ReSearch Pharmaceutical Services, Inc.
Information provided by (Responsible Party):
UCB Pharma ( UCB Pharma SA )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2014
  Actual Study Completion Date : March 2014